BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+20.82%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.42B
AUM Growth
+$2.42B
(+17%)
Cap. Flow
+$150M
Cap. Flow
% of AUM
6.2%
Top 10 Holdings %
Top 10 Hldgs %
42.31%
Holding
83
New
4
Increased
11
Reduced
18
Closed
3
Top Buys
| 1 |
Ionis Pharmaceuticals
IONS
|
$70.6M |
| 2 |
THRD
Third Harmonic Bio
THRD
|
$66.4M |
| 3 |
ALLK
Allakos
ALLK
|
$30.6M |
| 4 |
VERV
Verve Therapeutics
VERV
|
$22.3M |
| 5 |
Revolution Medicines
RVMD
|
$19.7M |
Top Sells
| 1 |
Arcus Biosciences
RCUS
|
$32.5M |
| 2 |
Xenon Pharmaceuticals
XENE
|
$25.2M |
| 3 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
$23M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$13.4M |
| 5 |
Merus
MRUS
|
$12.8M |
Sector Composition
| 1 | Healthcare | 98.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PHXM
76
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
| $690K | 0.03% |
1,314,656
| – | – |
|
|
NEUP
77
Neuphoria Therapeutics Inc. Common Stock
NEUP
$23.1M
| $578K | 0.02% |
80,971
| – | – |
|
78
Galmed Pharmaceuticals
GLMD
$7.07M
| $558K | 0.02% |
1,799,694
| – | – |
|
79
Rezolute
RZLT
$625M
| $523K | 0.02% |
190,815
| – | – |
|
|
CFRX
80
DELISTED
ContraFect Corporation
CFRX
| $79K | ﹤0.01% |
472,300
-3,500,000
| -88% | -$585K |
|
81
Celldex Therapeutics
CLDX
$1.55B
| – | – |
-154,000
| Closed | -$4.15M |
|
82
Protagonist Therapeutics
PTGX
$3.59B
| – | – |
-1,106,838
| Closed | -$8.76M |
|
83
Voyager Therapeutics
VYGR
$207M
| – | – |
-140,000
| Closed | -$827K |
|